null mutation of COX-2 markedly reduces the number and The M 3 muscarinic cholinergic receptor has important size of intestinal polyps in Apc ∆716 (adenomatous polyposis physiological functions on normal colonic cells. It is coli) knockout mice, a model for human familial adenomatous frequently expressed on human colon cancer cells and is polyposis (7). In addition, overexpression of COX-2 inhibits biologically active. Although it is mitogenic in certain apoptosis and increases the invasive potential of malignant cell models, the importance of this receptor on colon cells (8,9). Studies investigating the role of COX-2 in human carcinogenesis is unknown. In the present study we have disease have suggested that chronic activation of this enzyme determined expression of the M 3 receptor on human colon results in colon cell pathology. An understanding of the factors cancer tissue compared with matched normal tissue and affecting COX-2 expression would therefore provide insight examined the downstream effect of receptor activation in into colon cancer etiology.
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the HT-29 human colon carcinoma cell line. Using reverse
We have previously shown that the M 3 subtype of the transcription-PCR, M 3 receptor RNA expression was muscarinic cholinergic receptor is expressed on 60% of colon detected in all matched colon carcinoma and normal cancer cell lines analyzed (10). However, little is known about specimens from eight patients. Five of the eight (62%) the effect that activation of this G-protein-coupled muscarinic patients showed an up to 8-fold greater level of M 3 cholinergic receptor has on colon cancer biology, progression receptor expression in cancer compared with the matched or formation. M 3 receptor activation is coupled to the phosphonormal tissue. Exposure of HT-29 cells to carbachol, a lipase C (PLC) signaling cascade (11, 12) and the PLC-activated stable receptor agonist, results in a 10-fold increase in protein kinase C (PKC) pathway is a prototypic inducer of cyclooxygenase-2 (COX-2) protein. This induction of COX-2 (13, 14) .
COX-2 protein was dose dependent and was inhibited
We first established that M 3 receptors are relevant on human by the cholinergic receptor antagonist N-methylscopolcolon cancers by determining that all normal colon and cancer amine (NMS). Carbachol caused a dose-dependent tissues studied express the receptor. In 62% of patients the increase in prostaglandin E 2 (PGE 2 ), the main product of receptor is overexpressed on colon cancers. We therefore cyclooxygenase activity. The maximum stimulatory effect undertook an investigation to determine whether M 3 receptor (40-fold increase) was noted with 1 mM carbachol. The activation affects COX-2 expression and PGE 2 synthesis in increase in PGE 2 was completely abolished by NMS and colon cancer cell line HT-29, which is known to express by the COX-2 selective inhibitor NS398. This suggests functional M 3 receptors (11) . We show that stimulation of the that the M 3 receptor mediates PGE 2 production by a M 3 receptor up-regulates COX-2 protein expression, which mechanism involving COX-2. As COX-2 and PGE 2 are subsequently increases the release of PGE 2 . These findings known promoters of gastrointestinal cancer, these data suggest that activation of the M 3 receptor has a role in colon suggest that M 3 receptor activation may facilitate progrescarcinogenesis, in part through a COX-2 and PG pathway. sion of colon carcinoma, in part by a COX-2-mediated Colon cancer cell line HT-29 was obtained from the cellular mechanism.
American Type Culture Collection and cultured in McCoy's 5A medium supplemented with 10% fetal bovine serum,BRL, Gaithersburg, MD). First strand cDNA synthesis was performed on 1 µg total RNA using the random priming extension method. The reaction condition was as follows: 10 min at room temperature, 30 min at 42°C, 5 min at 95°C and 5 min at 4°C. PCR primers were designed according to the published human cDNA sequences. The primer sequences were: M 3 receptor (sense) 5Ј-CGAGACGAGAGCCATCTACTCC-3Ј; M 3 receptor (antisense) 5Ј-GACCAGGGACATCCTTTTC-CGC-3Ј; β-actin (sense) 5Ј-GGACGACATGGAGAAAA-TCTGG-3Ј; β-actin (antisense) 5Ј-GGATAGCAACGTA-CATGGCTGG-3Ј.
The predicted size of the PCR products for each of the primer pairs was 376 (M 3 ) and 171 (β-actin) bp. PCR was initiated by adding 2 µl of the RT reaction product into PCR reagent mix consisting of 20 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl 2 , 0.5 µM each primer, 2.5 U Taq DNA polymerase. PCR cycle conditions included denaturation for 30 s at 95°C, annealing for 30 s at 65°C for M 3 or 60°C for actin and extension for 30 s at 72°C. Each sample was subjected to PCR at multiple cDNA concentrations for [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] cycles to determine the range of linearity in amplification. The Cells were lysed for western blotting with RIPA buffer (150 mM NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 10 mM Tris, pH 7.2, 100 µM sodium cancer pathogenesis. This provided the basis for subsequent study of the role of the M 3 receptor in human colon cancer. orthovanadate, 50 mM sodium fluoride) containing protease inhibitor (Complete; Boehringer Mannheim, Indianapolis, IN).
HT-29 colon carcinoma cells contain a pure population of M 3 receptors, which are coupled to the PLC signaling cascade Lysates were frozen at -80°C for 15 min and centrifuged at 10 000 g for 10 min to remove the particulate sediment (11) . We used this well-defined model system to investigate the role of the M 3 receptor in human colon cancer. As COX-2 material. Protein concentration in the supernatant was measured using the Bio-Rad protein determination protocol. Total cellular is important in colon carcinogenesis and can be induced by a PLC-activated PKC pathway, we examined the effect of M 3 protein (50-60 µg) was separated by electrophoresis on a 7.5% SDS-polyacrylamide gel and electrotransferred onto PVDF receptor activation on COX-2 expression.
To determine the effect of M 3 receptor activation on COX-2 membrane. Membranes were incubated with anti-human COX-2 monoclonal antibody (Cayman Chemical, Ann Arbor, protein expression, HT-29 cells were exposed to increasing concentrations of carbachol (0.1 µM-1 mM) for 6 h. These MI) followed by horseradish peroxidase-labeled secondary antibody (Kirkegaard & Perry Laboratories, Gaithersburg, doses of carbachol have previously been shown to bind to the M 3 receptor (10). No cellular toxicity was noted at these MD). The signal was revealed using a chemiluminescence detection system (Kirkegaard & Perry Laboratories). agonist concentrations. Carbachol increased COX-2 protein expression in a concentration-dependent manner (Figure 2A ). To determine PGE 2 production, cells (5ϫ10 5 ) were plated in 60 mm dishes and grown to 60% confluence. The culture An increase in COX-2 was detected at a dose of 0.1 µM carbachol and the maximal increase in COX-2 was obtained medium was collected to determine the amount of PGE 2 secreted by the cells. PGE 2 production was determined by at 1 mM carbachol. The COX-2 response to carbachol was inhibited by the muscarinic cholinergic antagonist N-methylenzyme immunoassay (Cayman Chemical).
We determined the expression of M 3 receptor RNA in scopolamine (NMS) in a dose-dependent fashion ( Figure  2B ). Induction of COX-2 by carbachol was time dependent. normal human colon epithelium and in colon cancer tissue from the same patient. Colon cancers in various stages of Treatment of HT-29 cells with 1 mM carbachol resulted in an increase in COX-2 with a peak response (10-fold increase) progression were utilized, including Dukes stage B-D. M 3 receptor RNA expression was detected in the cancer and detected at 3 h ( Figure 2C ). PGE 2 is the main product of COX activity. We therefore matched normal specimens from all of the patients (Figure 1) . Five of eight patients (62%) showed an up to 8-fold increase sought to determine whether induction of COX-2 protein is associated with an increase in the release of PGE 2 by HT-29 in M 3 receptor expression in cancer tissue compared with the matched adjacent normal tissue. Three of these patients cells. HT-29 cells were incubated with (1 mM) or without carbachol for the indicated period of time. Carbachol stimulaexhibited twice the receptor expression in tumors compared with normal tissue (1.8, 2 and 2; Figure 1 ) and two patients tion resulted in a 40-fold increase in PGE 2 production after 3 h treatment ( Figure 3 ). The level of increase gradually exhibit a Ͼ5-fold increase in receptor expression in tumor compared with normal tissue (5.6 and 8.2; Figure 1 ). Increased returned to baseline, but a 10-fold increase in PGE 2 was still evident 24 h after treatment. levels of M 3 cholinergic receptor expression in colon cancer tissue suggests that the M 3 receptor is important in colon Carbachol-induced PGE 2 production was dose dependent at increase tumorigenic potential of several cell models (16) (17) (18) (19) .
The data represent the means Ϯ SD of three experiments.
To determine whether COX-2 is involved in carbachol-induced cell growth in NCI-H508 cells, we first studied the effect of carbachol on COX-2 expression in these cells as low levels concentrations ranging from 10 µM to 1 mM (Figure 4) . A 10-fold increase was noted at a concentration of 10 µM and of COX-2 RNA are detected using RT-PCR. Treatment of NCI-H508 cells with carbachol did not result in induction the maximum stimulatory effect (40-fold) was reached at a concentration of 1 mM. Carbachol-induced PGE 2 production of COX-2 (data not shown). Although carbachol elicits a mitogenic effect in NCI-H508 cells independent of COX-2 was completely abolished by NMS (1 µM), a competitive receptor antagonist ( Figure 5 ). In addition, the COX-2-specific induction, it does not stimulate the growth of HT-29 cells in which COX-2 levels are enhanced by receptor activation inhibitor NS398 completely inhibited PGE 2 production at a concentration known not to inhibit COX-1 ( Figure 5 ). This (data not shown). These data suggest that carbachol-induced COX-2 expression is not necessary for human colon cancer suggests that the carbachol-stimulated increase in PGE 2 production is a result of M 3 receptor-ligand binding which growth and that it is not sufficient to induce colon cancer growth. mediates its effect through COX-2 expression.
We have previously shown that the human colon cancer cell The gastrointestinal tract is the largest endocrine organ in the body. Physiological growth and function are regulated by line NCI-H508 contains functional M 3 receptors and that peptide growth hormones and neurotransmitters. Most of these the first time, to our knowledge, that the mechanism by which a G-protein-coupled cholinergic receptor involved in colon biological regulators bind to specific receptors belonging to a superfamily of seven transmembrane domain G-proteincarcinogenesis has been delineated.
In conclusion,we demonstrate that M 3 receptors are expressed coupled receptors. It is well established that the colon is inervated by cholinergic nerve endings and is constantly in all human colon tissues analyzed and are frequently overexpressed in human colon cancer compared with normal colon exposed to the neurotransmitter acetylcholine (20) . We have previously shown that human colon cancer cell lines frequently tissue. Activation of this M 3 receptor up-regulates COX-2 and results in PGE 2 production. This suggests that M 3 receptors possess functional muscarinic cholinergic receptors of the M 3 subtype (10). The naturally occurring ligand for this receptor may contribute to the malignant progression of human colon carcinoma and warrants further study. is the neurotransmitter acetylcholine. In the present study we have demonstrated that the M 3 receptor is expressed in all human colon tissues analyzed and that the receptor is frequently Acknowledgement overexpressed on cancer tissue compared with normal adjacent tissue. Previous study has shown that M 3 receptor activation This work was funded by NIH grant CA70335 (to H.F.).
can induce neoplastic transformation (16) and changes in adhesion activity in some cell systems (17). It is possible that References M 3 receptor expression confers an advantage to human colon cancer cells by decreasing apoptosis or facilitating metastatic
